An assessment of Movement Disorder Society Task Force diagnostic criteria for mild cognitive impairment in Parkinson's disease

Uysal-Canturk P., Hanagasi H. A., Bilgic B., Gurvit H., Emre M.

EUROPEAN JOURNAL OF NEUROLOGY, cilt.25, sa.1, ss.148-153, 2018 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 25 Sayı: 1
  • Basım Tarihi: 2018
  • Doi Numarası: 10.1111/ene.13467
  • Dergi Adı: EUROPEAN JOURNAL OF NEUROLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.148-153
  • Anahtar Kelimeler: mild cognitive impairment, Parkinson's disease, DEMENTIA, VALIDITY, MOCA, MCI
  • İstanbul Üniversitesi Adresli: Evet

Özet

Background and purposeCognitive impairment is one of the most disabling non-motor symptoms of Parkinson's disease. Mild cognitive impairment constitutes a major risk for the development of Parkinson's disease dementia in the course of the disease. A Movement Disorder Society Task Force proposed diagnostic criteria for mild cognitive impairment in Parkinson's disease (PD-MCI), comprising two operational levels: Level I and Level II. The objective of our study was to test the accuracy of Level I versus Level II diagnostic criteria.